Amgen Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
167 result(s) found, displaying 51 to 60
-
-
Australian Public Assessment Report (AusPAR)AusPAR for Lumakras (sotorasib) for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) who have received at least one prior systemic therapy for advanced disease.
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LUMAKRAS sotorasib 120 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Amgen Australia Pty Ltd - Subcutaneous/intramuscular injection set, medicated.
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Prescription medicine registrationActive ingredients: carfilzomib.
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd